Title: 3. Noncash Assistance
Accounting Policies: The consolidated financial statements contained in Hartford HealthCare Corporation and Subsidiaries’ (the Corporation) annual audit report are prepared on the accrual basis of accounting. Refer to the notes to the consolidated financial statements for a summary of the significant accounting policies. The accompanying Schedule of Expenditures of Federal Awards (the Schedule) for the year ended September 30, 2023 includes the federal grant activity of the Corporation and is presented on the accrual basis of accounting. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance) and other program-specific guidance (see Notes 5 and 6). In accordance with certain requirements, certain grants are not dependent on expenditure activity and, accordingly, such grants are considered to be expended in the fiscal year of receipt; the grant program receipts of such awards are reflected in the expenditures column of the Schedule. Other programs may be presented in a certain fiscal year based on the program-specific guidance (see Notes 5 and 6). Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the Corporation’s consolidated financial statements. Direct and indirect costs are charged to awards in accordance with cost principles contained in the United States Department of Health and Human Services Cost Principles for Hospitals at 45 CFR Part 75 Appendix IX. Under these cost principles, certain types of expenditures are not allowable or are limited as to reimbursement.
De Minimis Rate Used: Both
Rate Explanation: The Uniform Guidance provides for a 10% de minimis indirect cost rate election. The Corporation uses a combination of a federally negotiated rate, award-specific rates, or the 10% de minimis rate by entity and program.
During the year ended September 30, 2023, the U.S. Department of Health and Human Services issued $148,114 in Federal vaccines to the Corporation through the Immunization Cooperative Agreements program (Assistance Listing No. 93.268). These federal funds, which were passed through the State of Connecticut Department of Public Health, are included in the accompanying Schedule.
Title: 4. Consolidated Reporting
Accounting Policies: The consolidated financial statements contained in Hartford HealthCare Corporation and Subsidiaries’ (the Corporation) annual audit report are prepared on the accrual basis of accounting. Refer to the notes to the consolidated financial statements for a summary of the significant accounting policies. The accompanying Schedule of Expenditures of Federal Awards (the Schedule) for the year ended September 30, 2023 includes the federal grant activity of the Corporation and is presented on the accrual basis of accounting. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance) and other program-specific guidance (see Notes 5 and 6). In accordance with certain requirements, certain grants are not dependent on expenditure activity and, accordingly, such grants are considered to be expended in the fiscal year of receipt; the grant program receipts of such awards are reflected in the expenditures column of the Schedule. Other programs may be presented in a certain fiscal year based on the program-specific guidance (see Notes 5 and 6). Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the Corporation’s consolidated financial statements. Direct and indirect costs are charged to awards in accordance with cost principles contained in the United States Department of Health and Human Services Cost Principles for Hospitals at 45 CFR Part 75 Appendix IX. Under these cost principles, certain types of expenditures are not allowable or are limited as to reimbursement.
De Minimis Rate Used: Both
Rate Explanation: The Uniform Guidance provides for a 10% de minimis indirect cost rate election. The Corporation uses a combination of a federally negotiated rate, award-specific rates, or the 10% de minimis rate by entity and program.
The federal award activity of the entities noted below is included in the accompanying Schedule for the year ended September 30, 2023 (See the Notes to the SEFA for table)
Title: 5. COVID-19 Disaster Grants Public Assistance (Presidentially Declared
Accounting Policies: The consolidated financial statements contained in Hartford HealthCare Corporation and Subsidiaries’ (the Corporation) annual audit report are prepared on the accrual basis of accounting. Refer to the notes to the consolidated financial statements for a summary of the significant accounting policies. The accompanying Schedule of Expenditures of Federal Awards (the Schedule) for the year ended September 30, 2023 includes the federal grant activity of the Corporation and is presented on the accrual basis of accounting. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance) and other program-specific guidance (see Notes 5 and 6). In accordance with certain requirements, certain grants are not dependent on expenditure activity and, accordingly, such grants are considered to be expended in the fiscal year of receipt; the grant program receipts of such awards are reflected in the expenditures column of the Schedule. Other programs may be presented in a certain fiscal year based on the program-specific guidance (see Notes 5 and 6). Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the Corporation’s consolidated financial statements. Direct and indirect costs are charged to awards in accordance with cost principles contained in the United States Department of Health and Human Services Cost Principles for Hospitals at 45 CFR Part 75 Appendix IX. Under these cost principles, certain types of expenditures are not allowable or are limited as to reimbursement.
De Minimis Rate Used: Both
Rate Explanation: The Uniform Guidance provides for a 10% de minimis indirect cost rate election. The Corporation uses a combination of a federally negotiated rate, award-specific rates, or the 10% de minimis rate by entity and program.
The Corporation incurred eligible disaster expenditures related to the COVID-19 pandemic. After a presidentially declared disaster, the Federal Emergency Management Agency (FEMA) provides Disaster Grants – Public Assistance (Presidentially Declared Disasters) (Assistance Listing No. 97.036) to reimburse eligible costs. In fiscal year 2023, FEMA approved $118,374,630 of eligible expenditures that were incurred in prior fiscal years. This amount has been included in the accompanying Schedule for the year ended September 30, 2023 in accordance with the guidance specific to Assistance Listing No. 97.036.
Title: 6. COVID-19 Provider Relief Fund
Accounting Policies: The consolidated financial statements contained in Hartford HealthCare Corporation and Subsidiaries’ (the Corporation) annual audit report are prepared on the accrual basis of accounting. Refer to the notes to the consolidated financial statements for a summary of the significant accounting policies. The accompanying Schedule of Expenditures of Federal Awards (the Schedule) for the year ended September 30, 2023 includes the federal grant activity of the Corporation and is presented on the accrual basis of accounting. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance) and other program-specific guidance (see Notes 5 and 6). In accordance with certain requirements, certain grants are not dependent on expenditure activity and, accordingly, such grants are considered to be expended in the fiscal year of receipt; the grant program receipts of such awards are reflected in the expenditures column of the Schedule. Other programs may be presented in a certain fiscal year based on the program-specific guidance (see Notes 5 and 6). Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the Corporation’s consolidated financial statements. Direct and indirect costs are charged to awards in accordance with cost principles contained in the United States Department of Health and Human Services Cost Principles for Hospitals at 45 CFR Part 75 Appendix IX. Under these cost principles, certain types of expenditures are not allowable or are limited as to reimbursement.
De Minimis Rate Used: Both
Rate Explanation: The Uniform Guidance provides for a 10% de minimis indirect cost rate election. The Corporation uses a combination of a federally negotiated rate, award-specific rates, or the 10% de minimis rate by entity and program.
In accordance with the requirements specific to Assistance Listing No. 93.498, COVID-19 – Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution, the amount presented on the accompanying Schedule for the year ended September 30, 2023 relates to Provider Relief Fund (PRF) payments received from July 1, 2021 through June 30, 2022 used for PRF-eligible activity from the period January 1, 2020 through June 30, 2023. This activity period and payment receipt period and the resulting amount presented reconciles to the PRF information previously reported to the Health Resources and Services Administration (HRSA) for PRF Reporting Periods 4 and 5, as follows (See the Notes to the SEFA for table)
The expenses attributable to Coronavirus Disease 2019 (COVID-19) and lost revenues incurred by the Corporation during the period of availability for PRF Reporting Period 4 (January 1, 2020 through December 31, 2022) and PRF Reporting Period 5 (January 1, 2020 through June 30, 2023) are in excess of the general and targeted distributions received in PRF Reporting Periods 1, 2 and 3 (which addressed payments received during April 10, 2020 to June 30, 2021, and previously reported on the applicable schedule of expenditures of federal awards for the years ended September 30, 2021 and 2022) and distributions received from July 1, 2021 through June 30, 2022 and, therefore, the amounts presented in the table above and on the accompanying Schedule are limited to the amount of such distributions. The Corporation received additional PRF payments subsequent to June 30, 2022 which are required to be reported in subsequent HRSA PRF Reporting Periods and, accordingly, pursuant to the requirements specific to Assistance Listing No. 93.498, such amounts are excluded from the accompanying Schedule.